Patient, provider groups unite behind SOAR Act in year-end push
AAHomecare joined a broad coalition of patient, clinician, and industry organizations urging congressional leaders to include the SOAR Act in year-end legislation.
In a Nov. 10 letter, the groups urged Senate Majority Leader John Thune (R-SD), Senate Minority Leader Chuck Schumer (D-NY), House Speaker Mike Johnson (R-LA) and House Minority Leader Hakeem Jeffries (D-NY) to include the bipartisan Supplemental Oxygen Access Reform Act (H.R. 2902/S. 1406) in any end-of-year health care package.
Signers include the American Lung Association, American Thoracic Society, COPD Foundation, Pulmonary Fibrosis Foundation, American Association for Respiratory Care, VGM, and AAHomecare, among 31 organizations in all.
More than 1.5 million Americans rely on supplemental oxygen. The SOAR Act would address “well-documented access problems driven by the deep payment cuts resulting from the” competitive bidding program.
The letter explains that a single standard Medicare inpatient admission for a COPD exacerbation is estimated at roughly $10,600 to $12,100 in 2026, while continuous oxygen therapy cost about $1,790 per patient per year in 2025.
The 119th Congress adjourns at year’s end, and lead House sponsor Rep. David Valadao (R-CA) will not return in January. Bills that don’t pass must be reintroduced and start over in the 120th Congress.
Call your Representative this week and urge them to include the SOAR Act (H.R. 2902) in year-end legislation. You can reach the Capitol switchboard at (202) 224-3121.